All In Biotech

Drug Trial Radar · NCT00004414

Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis

Last checked: Nov 19, 2026Latest source record: Mar 25, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 252 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

252

Actual

Start

Sep 1997

Primary completion

Not stated

Study completion Jun 2002

Sponsor

Lead sponsor
University of MichiganAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 19, 1999

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, up to 30 days
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

OBJECTIVES: I. Compare conjugated bilirubin levels and serum bile acid levels in severely premature newborns on long term parenteral nutrition and given either sincalide or placebo. II. Compare morbidity and mortality rates in this patient population. III. Evaluate ultrasonographic images of the hepatobiliary tree during and 1 to 2 years after the administration of sincalide or placebo to assess the development of biliary sludge and biliary stone formation.

Conditions

  • Cholestasis

Interventions

  • sincalideDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Johns Hopkins Oncology Center

    Baltimore, Maryland

  • University of Michigan Medical School

    Ann Arbor, Michigan

  • University of Rochester Medical Center

    Rochester, New York

  • Children's Hospital Medical Center - Cincinnati

    Cincinnati, Ohio

  • Rhode Island Hospital

    Providence, Rhode Island

  • Baylor University Medical Center

    Dallas, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.